Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valsartan”

374 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 374 results

Post-approval studies (Phase 4)UnknownNCT02299310
What this trial is testing

Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Chinese PLA General Hospital 60
Post-approval studies (Phase 4)Study completedNCT01819220
What this trial is testing

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Who this might be right for
Hypertension
Yonsei University 16
Post-approval studies (Phase 4)Study completedNCT04023227
What this trial is testing

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Who this might be right for
Chagas DiseaseHeart Failure
Novartis Pharmaceuticals 922
Testing effectiveness (Phase 2)Looking for participantsNCT06053580
What this trial is testing

Repurposing Valsartan May Protect Against Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial HypertensionRight Heart FailureRight Ventricular Dysfunction+1 more
University of Washington 60
Early research (Phase 1)Study completedNCT01764178
What this trial is testing

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

Who this might be right for
HyperlipidemiaHypertension
JW Pharmaceutical 52
Not applicableWithdrawnNCT00627991
What this trial is testing

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Who this might be right for
Cerebrovascular Accident
Stanford University
Not applicableActive Not RecruitingNCT07465679
What this trial is testing

A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Novartis Pharmaceuticals 500
Post-approval studies (Phase 4)Study completedNCT00687973
What this trial is testing

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

Who this might be right for
Hypertension
Novartis Pharmaceuticals 393
Not applicableLooking for participantsNCT07192341
What this trial is testing

Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction

Who this might be right for
Sacubitril/ValsartanProsthetic Heart ValveHeart Failure+1 more
Kafrelsheikh University 220
Large-scale testing (Phase 3)Study completedNCT00376272
What this trial is testing

GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

Who this might be right for
Atrial Fibrillation
Gruppo di Ricerca GISSI 1,442
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139405
What this trial is testing

TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT

Who this might be right for
Type 2 Diabetes (T2DM)
Myopharm Limited 90
Large-scale testing (Phase 3)Study completedNCT00254475
What this trial is testing

Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Who this might be right for
Essential HypertensionHypercholesterolemia
Novartis 871
Large-scale testing (Phase 3)Study completedNCT00171041
What this trial is testing

Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age

Who this might be right for
Hypertension
Novartis 265
Post-approval studies (Phase 4)Study completedNCT00409487
What this trial is testing

Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients

Who this might be right for
Hypertension,Obstructive Sleep Apnea
University Hospital, Grenoble 60
Testing effectiveness (Phase 2)WithdrawnNCT03415906
What this trial is testing

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

Who this might be right for
Heart Failure
Hannover Medical School
Large-scale testing (Phase 3)Study completedNCT06149104
What this trial is testing

A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 8
Early research (Phase 1)WithdrawnNCT01432106
What this trial is testing

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Who this might be right for
HypertensionMetabolic Syndrome
University of Michigan
Testing effectiveness (Phase 2)Study completedNCT00549770
What this trial is testing

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 1,334
Post-approval studies (Phase 4)Study completedNCT02874794
What this trial is testing

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

Who this might be right for
Heart Failure and Reduced Ejection Fraction
Novartis Pharmaceuticals 465
Post-approval studies (Phase 4)UnknownNCT00874601
What this trial is testing

Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Hallym University Medical Center 578
Load More Results